|
"Antibody Engineering", vol. 1, 2010, SPRINGER PROTOCOLS, pages: 657 - 665
|
|
"GenBank", Database accession no. NM_001008725.3
|
|
"Handbook of Pharmaceutical Excipients", 1994
|
|
"Prospective Studies Collaboration", LANCET, vol. 373, no. 9669, 2009, pages 1083 - 96
|
|
"Remington's Pharmaceutical Sciences", 1990, LIPPINCOTT, WILLIAMS & WILKINS
|
|
"UniProt", Database accession no. P40189-1
|
|
"UniProtKB", Database accession no. P47873
|
|
ABBAS-TERKI, T.W. BLANCO-BOSEN. DEGLONW. PRALONGP. AEBISCHER: "Lentiviral-mediated RNA interference", HUM GENE THER., vol. 13, 2002, pages 2197 - 201, XP002978528
|
|
ALBHAISI ET AL., F1000 FACULTY REV-720, 2018, pages 7
|
|
ANTHONY J. BROOKES: "The essence of SNPs", GENE, vol. 234, no. 2, 8 July 1999 (1999-07-08), pages 177 - 186
|
|
BAENA ET AL., SCI REP, vol. 6, 2016, pages 26149
|
|
BAENA MSANGIIESA GHUTTER N ET AL.: "Liquid fructose in Western-diet-fed mice impairs liver insulin signalling and causes cholesterol and triglyceride loading without changing calorie intake and body weight", J NUTR BIOCHEM, vol. 40, 2017, pages 105 - 115, XP029878690
|
|
BAEUERLE, PA ET AL., CANCER RES, vol. 69, no. 12, 2009, pages 4941 - 4944
|
|
BANINI BASANYAL AJ: "Current and future pharmacologic treatment of nonalcoholic steatohepatitis", CURR OPIN GASTROENTEROL, vol. 33, 2017, pages 134 - 141
|
|
BANSAL WORLD J DIABETES, vol. 6, no. 2, 2015, pages 296 - 303
|
|
BARBAS ET AL., PROC NAT. ACAD. SCI. USA, vol. 91, 1994, pages 3809 - 3813
|
|
BARTON, G.M.R. MEDZHITOV: "Retroviral delivery of small interfering RNA into primary cells", PROC NATL ACAD SCI USA., vol. 99, 2002, pages 14943 - 5, XP002328325
|
|
BARTONMEDZHITOV, PNAS, vol. 99, no. 23, 12 November 2002 (2002-11-12), pages 14943 - 14945
|
|
BEAUCAGE, S. L.LYER, R. P., TETRAHEDRON, vol. 48, no. 12, 1992, pages 2223
|
|
BENEDICTZHANG, WORLD J HEPATOL., vol. 9, no. 16, 2017, pages 715 - 732
|
|
BERGLUND ET AL., J. CLIN. ENDOCRINOL. METAB., vol. 97, no. 9, 2012, pages 2969 - 89
|
|
BERNSTEIN, E. ET AL., NATURE, vol. 411, 2001, pages 494 - 498
|
|
BERRINGTON DE GONZALEZ ET AL., N ENGL J MED, vol. 363, 2010, pages 2211 - 2219
|
|
BHATNAGAR ET AL., BMJ, vol. 337, 2008, pages a993
|
|
BLANC ET AL., J. IMMUNOL METHODS, vol. 241, no. 1-2, 31 July 2000 (2000-07-31), pages 43 - 59
|
|
BLUHER ET AL., NAT REV ENDOCRINOL., vol. 15, 2019, pages 288 - 298
|
|
BOCKHORN ET AL., NAT. COMMUN., vol. 4, no. 0, 2013, pages 1393
|
|
BOLGER AMLOHSE MUSADEL B: "Trimmomatic: a flexible trimmer for Illumina sequence data", BIOINFORMATICS, vol. 30, 2014, pages 2114 - 2120
|
|
BONNER-WEIRO'BRIEN, DIABETES, vol. 57, 2008, pages 2899 - 2904
|
|
BORKHARDT, A.: "Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?", CANCER CELL., vol. 2, 2002, pages 167 - 8, XP009006463
|
|
BRISCHOUX-BOUCHER ETRIMOUILLE ABAUJAT G ET AL.: "IL11 RA-related Crouzon-like autosomal recessive craniosynostosis in ten new patients: resemblances and differences", CLIN GENET, 2018, Retrieved from the Internet <URL:http://dx.doi.org/10.1111/cge.13409>
|
|
CHEW VLAI LPAN L ET AL.: "Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses", PROC NATL ACAD SCI U S A, vol. 114, 2017, pages E5900 - E5909
|
|
CHOTHIA ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
|
|
CONCEPCION ET AL., COMB CHEM HIGH THROUGHPUT SCREEN, vol. 12, no. 8, September 2009 (2009-09-01), pages 791 - 800
|
|
COOK SNG BDONG J ET AL., IL-11 IS A THERAPEUTIC TARGET IN IDIOPATHIC PULMONARY FIBROSIS, 2018, Retrieved from the Internet <URL:http://dx.doi.org/10.1101/336537>
|
|
CURTIS ET AL., BLOOD, vol. 90, no. 11, 1 December 1997 (1997-12-01), pages 4403 - 12
|
|
D. M.BAST, B. J.: "Production of Bispecific Antibodies", CURRENT PROTOCOLS IN IMMUNOLOGY, vol. 14, no. IV, 2001, pages 2.13,2.13.1 - 2.13.16
|
|
DAMS-KOZLOWSKA HGRYSKA KKWIATKOWSKA-BOROWCZYK E ET AL.: "A designer hyper interleukin 11 (H11) is a biologically active cytokine", BMC BIOTECHNOL, vol. 12, 2012, pages 8, XP021095068
|
|
DE-CHAO YU ET AL., MOLECULAR THERAPY, vol. 20, no. 5, 2012, pages 938 - 947
|
|
DEFRONZO, NATURE REVIEWS DISEASE PRIMERS, vol. 1, 2015, pages 15019
|
|
DEVROE, E.P.A. SILVER: "Retrovirus-delivered siRNA", BMC BIOTECHNOL., vol. 2, 2002, pages 15, XP021017015
|
|
DOBIN ADAVIS CASCHLESINGER F ET AL.: "STAR: ultrafast universal RNA-seq aligner", BIOINFORMATICS, vol. 29, 2013, pages 15 - 21, XP055500895
|
|
DOU CLIU ZTU K ET AL.: "P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts", GASTROENTEROLOGY, vol. 154, 2018, pages 2209 - 2221,e14
|
|
DZAU ET AL., TRENDS IN BIOTECHNOLOGY, vol. 11, 2003, pages 205 - 210
|
|
ELBASHIR, S. M. ET AL., GENES DEV., vol. 15, 2001, pages 188 - 200
|
|
ELSHARKAWY AMOAKLEY FMANN DA: "The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis", APOPTOSIS, vol. 10, 2005, pages 927 - 939, XP019204731
|
|
EVANS ET AL., CLIN NUTR., vol. 6, 2008, pages 793 - 9
|
|
FAN ET AL.: "Highly Parallel SNP Genotyping", COLD SPRING HARB SYMP QUANT BIOL, vol. 68, 2003, pages 69 - 78, XP001538040
|
|
FEARON ET AL., J CACHEXIA SARCOPENIA MUSCLE, vol. 2, 2011, pages 1 - 3
|
|
FEARON ET AL., LANCET ONCOL., vol. 12, no. 5, 2011, pages 489 - 95
|
|
FIORENZA ET AL., NATURE REVIEWS ENDOCRINOLOGY, vol. 7, 2011, pages 137 - 150
|
|
FIRE A ET AL., NATURE, vol. 391, 1998, pages 806 - 811
|
|
FIRE, A., TRENDS GENET, vol. 15, 1999, pages 358 - 363
|
|
FONTAINE ET AL., JAMA, vol. 289, 2003, pages 187 - 193
|
|
FRENCH: "How to make bispecific antibodies", METHODS MOL. MED., vol. 40, 2000, pages 333 - 339
|
|
FRIEDMAN ET AL., NAT MED., vol. 24, no. 7, 2018, pages 908 - 922
|
|
FRIEDMAN SL: "Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver", PHYSIOL REV, vol. 88, 2008, pages 125 - 172
|
|
FRIEDMAN SL: "Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury", J BIOL CHEM, vol. 275, 2000, pages 2247 - 2250, XP002976213
|
|
FRIEDMAN SLNEUSCHWANDER-TETRI BARINELLA M ET AL.: "Mechanisms of NAFLD development and therapeutic strategies", NAT MED, 2018, Retrieved from the Internet <URL:http://dx.doi.org/10.1038/s41591-018-0104-9>
|
|
GARBERSSCHELLER, BIOL. CHEM., vol. 394, no. 9, 2013, pages 1145 - 1161
|
|
GOLD L ET AL., PLOS ONE, vol. 5, no. 12, 2010, pages e15004
|
|
GOMES ALTEIJEIRO ABUREN S ET AL.: "Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma", CANCER CELL, vol. 30, 2016, pages 161 - 175, XP029636918
|
|
HAMILTON, A. ET AL., SCIENCE, vol. 286, 1999, pages 950 - 952
|
|
HAMMOND, S. M. ET AL., NATURE REV. GENET., vol. 2, 2001, pages 110 - 1119
|
|
HAMMOND, S. M. ET AL., NATURE, vol. 404, 2000, pages 293 - 296
|
|
HANNON, G.J.: "RNA interference", NATURE, vol. 418, 2002, pages 244 - 51, XP002979088
|
|
HAWKINS ET AL., J. MOL. BIOL., vol. 226, 1992, pages 889 - 896
|
|
HEARTY ET AL., METHODS MOL BIOL, vol. 907, 2012, pages 411 - 442
|
|
HELLERBRAND CSTEFANOVIC BGIORDANO F ET AL.: "The role of TGFpl in initiating hepatic stellate cell activation in vivo", J HEPATOL, vol. 30, 1999, pages 77 - 87
|
|
HEMMANN SGRAF JRODERFELD M ET AL.: "Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies", J HEPATOL, vol. 46, 2007, pages 955 - 975, XP022024103
|
|
HIGASHI TFRIEDMAN SLHOSHIDA Y: "Hepatic stellate cells as key target in liver fibrosis", ADV DRUG DELIV REV, vol. 121, 2017, pages 27 - 42, XP085293218
|
|
HILTON ET AL., EMBO J, vol. 13, 1994, pages 4765
|
|
HORNIGFARBER-SCHWARZ: "Antibody Engineering: Methods and Protocols", 2012, HUMANA PRESS, article "Production of Bispecific Antibodies: Diabodies and Tandem scFv"
|
|
IWAISAKO KJIANG CZHANG M ET AL.: "Origin of myofibroblasts in the fibrotic liver in mice", PROC NATL ACAD SCI U S A, vol. 111, 2014, pages E3297 - 305
|
|
J G R HURRELL: "Monoclonal Hybridoma Antibodies: Techniques and Applications", 1982, CRC PRESS
|
|
JACKSON ET AL., J. IMMUNOL., vol. 154, no. 7, 1995, pages 331 0 - 15 9
|
|
JANSEN ET AL., HEPATOLOGY, vol. 65, no. 2, 2017, pages 722 - 738
|
|
JATOI ET AL., J CLIN ONCOL., vol. 22, 2004, pages 2469 - 76
|
|
JERABEK-WILLEMSEN ET AL., ASSAY DRUG DEV TECHNOL., vol. 9, no. 4, August 2011 (2011-08-01), pages 342 - 353
|
|
JOHN ET AL., PLOS BIOLOGY, vol. 11, no. 2, 2004, pages 1862 - 1879
|
|
KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1991, PUBLIC HEALTH SERVICE, NATIONAL INSTITUTES OF HEALTH
|
|
KAHANOVITZ ET AL., POINT CARE, vol. 16, no. 1, 2017, pages 37 - 40
|
|
KAMPMANN ET AL., WORLD J DIABETES, vol. 6, no. 8, 2015, pages 1065 - 1072
|
|
KARPOVICH ET AL., MOL. HUM. REPROD., vol. 9, no. 2, 2003, pages 75 - 80
|
|
KATARIA ET AL., SEMIN IMMUNOPATHOL., 2010
|
|
KATOHSTANDLEY, MOLECULAR BIOLOGY AND EVOLUTION, vol. 30, no. 4, 2013, pages 772 - 780
|
|
KIM B-MABDELFATTAH AMVASAN R ET AL.: "Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis", SCI REP, vol. 8, 2018, pages 7499
|
|
KISSELEVA TCONG MPAIK Y ET AL.: "Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis", PROC NATL ACAD SCI U S A, vol. 109, 2012, pages 9448 - 9453
|
|
KONNERDUPONT, CLIN COLORECTAL CANCER, vol. 4, no. 2, October 2004 (2004-10-01), pages 81 - 5
|
|
KONTERMANN, MABS, vol. 4, no. 2, 2012, pages 182 - 197
|
|
KOYAMA YBRENNER DA: "Liver inflammation and fibrosis", J CLIN INVEST, vol. 127, 2017, pages 55 - 64
|
|
KRIZHANOVSKY VYON MDICKINS RA ET AL.: "Senescence of activated stellate cells limits liver fibrosis", CELL, vol. 134, 2008, pages 657 - 667, XP055451638
|
|
LAD ET AL., J BIOMOL SCREEN, vol. 20, no. 4, 2015, pages 498 - 507
|
|
LANCET, vol. 390, no. 10113, 2017, pages 26227 - 2642
|
|
LASSMANNSONNHAMMER, BMC BIOINFORMATICS, vol. 6, no. 298, 2005
|
|
LAU JKCZHANG XYU J: "Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances", J PATHOL, vol. 241, 2017, pages 36 - 44
|
|
LAWAN ABENNETT AM: "Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism", TRENDS ENDOCRINOL METAB, vol. 28, 2017, pages 868 - 878, XP085251889
|
|
LAWITZ EJHEPBURN MJCASEY TJ: "A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy", AM J GASTROENTEROL, vol. 99, 2004, pages 2359 - 2364
|
|
LAY ET AL., INT. J. ONCOL., vol. 41, no. 2, 2012, pages 759 - 764
|
|
LEE ET AL., AM J RESPIRE CELL MOL BIOL., vol. 39, no. 6, December 2008 (2008-12-01), pages 739 - 746
|
|
LEE ET AL., DIABETES CARE, vol. 34, 2011, pages 353 - 357
|
|
LEWIS, D.L.J.E. HAGSTROMA.G. LOOMISJ.A. WOLFFH. HERWEIJER: "Efficient delivery of siRNA for inhibition of gene expression in postnatal mice", NAT GENET., vol. 32, 2002, pages 107 - 8, XP002978928
|
|
LIAO YSMYTH GKSHI W: "The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote", NUCLEIC ACIDS RES, vol. 41, 2013, pages e108
|
|
LIBERZON ASUBRAMANIAN APINCHBACK R ET AL.: "Molecular signatures database (MSigDB) 3.0", BIOINFORMATICS, vol. 27, 2011, pages 1739 - 1740
|
|
LOKAU ET AL., CELL REPORTS, vol. 14, 2016, pages 1761 - 1773
|
|
LORI, F.P. GUALLINIL. GALLUZZIJ. LISZIEWICZ: "Gene therapy approaches to HIV infection", AM J PHARMACOGENOMICS, vol. 2, 2002, pages 245 - 52
|
|
LOVE MIHUBER WANDERS S: "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", GENOME BIOL, vol. 15, 2014, pages 550, XP021210395
|
|
MACHADO MVMICHELOTTI GAXIE G ET AL.: "Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease", PLOS ONE, vol. 10, 2015, pages e0127991
|
|
MARKS ET AL., RIOLTECHNOLOGY, vol. 10, 1992, pages 779 - 783
|
|
MARRA FVALENTE AJPINZANI M ET AL.: "Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines", J CLIN INVEST, vol. 92, 1993, pages 1674 - 1680
|
|
MATSUZAKI ET AL.: "Parallel Genotyping of Over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array", GENOME RES., vol. 14, 2004, pages 414 - 425, XP002430641
|
|
MATTA, H.B. HOZAYEVR. TOMARP. CHUGHP.M. CHAUDHARY: "Use of lentiviral vectors for delivery of small interfering RNA", CANCER BIOL THER., vol. 2, 2003, pages 206 - 10, XP001180107
|
|
MCMANUS, M.T.P.A. SHARP.: "Gene silencing in mammals by small interfering RNAs", NAT REV GENET., vol. 3, 2002, pages 737 - 47, XP002352198
|
|
MEDERACKE IHSU CCTROEGER JS ET AL.: "Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology", NAT COMMUN, vol. 4, 2013, pages 2823
|
|
MENKE ET AL., JAMA, vol. 314, 2015, pages 1021 - 1029
|
|
MENKHORST ET AL., BIOLOGY OF REPRODUCTION, vol. 80, no. 5, 1 May 2009 (2009-05-01), pages 920 - 927
|
|
MORRIS, M.C.L. CHALOINF. HEITZG. DIVITA: "Translocating peptides and proteins and their use for gene delivery", CURR OPIN BIOTECHNOL., vol. 11, 2000, pages 461 - 6, XP001022944
|
|
MORRISON ET AL., PROC. NATL. ACAD. SD. USA, vol. 81, 1984, pages 6851 - 6855
|
|
MUELLER, D ET AL., BIODRUGS, vol. 24, no. 2, 2010, pages 89 - 98
|
|
MYERS, NATURE BIOTECHNOLOGY, vol. 21, 2003, pages 324 - 328
|
|
MYSZKA DG: "Improving biosensor analysis", J MOL RECOGNIT, vol. 12, 1999, pages 279 - 284
|
|
NANDURKAR ET AL., ONCOGENE, vol. 12, 1996, pages 585
|
|
NANDURKAR HHROBB LTARLINTON D ET AL.: "Adult mice with targeted mutation of the interleukin-11 receptor (IL11 Ra) display normal hematopoiesis", BLOOD, vol. 90, no. 11, 1997, pages 2148 - 2159
|
|
NATURE, vol. 457, no. 7228, 22 January 2009 (2009-01-22), pages 426 - 433
|
|
NEUBERGER ET AL., 8TH INTERNATIONAL BIOTECHNOLOGY SYMPOSIUM PART 2, 1988, pages 792 - 799
|
|
NORDAN, R. P. ET AL., J. IMMUNOL., vol. 139, 1987, pages 813
|
|
NOTREDAME ET AL., J. MOL. BIOL., vol. 302, 2000, pages 205 - 217
|
|
ORZANOSCOTT, J AM BOARD FAM PRACT, vol. 17, no. 5, 2004, pages 359 - 369
|
|
PASQUALINI ET AL., CANCER, vol. 121, no. 14, 2015, pages 2411 - 2421
|
|
PAUL, C.P.P.D. GOODI. WINERD.R. ENGELKE: "Effective expression of small interfering RNA in human cells", NAT BIOTECHNOL., vol. 20, 2002, pages 505 - 8, XP001121066
|
|
PETER STARKEL, GUT, vol. 57, 2008, pages 440 - 442
|
|
PFLANZ ET AL., FEBS LETT, vol. 450, 1999, pages 117 - 122
|
|
PHAM ET AL., F1000 FACULTY REV-607, 2018, pages 7
|
|
POLLOCKMINUK, J GASTROENTEROL HEPATOL, vol. 32, no. 7, 2017, pages 1303 - 1309
|
|
PUTOCZKIERNST, J LEUKOC BIOL, vol. 88, no. 6, 2010, pages 1109 - 1117
|
|
QIN, X.F.D.S. ANI.S. CHEND. BALTIMORE: "Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5", PROC NATL ACAD SCI USA., vol. 100, 2003, pages 183 - 8, XP002975768
|
|
RETTER ET AL., NUCL. ACIDS RES., vol. 33, no. 1, 2005, pages D671 - D674
|
|
REVERDATTO ET AL., CURR TOP MED CHEM., vol. 15, no. 12, 2015, pages 1082 - 101
|
|
RICH ET AL., ANAL BIOCHEM., vol. 373, no. 1, 1 February 2008 (2008-02-01), pages 112 - 20
|
|
RINELLA MEELIAS MSSMOLAK RR ET AL.: "Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet", J LIPID RES, vol. 49, 2008, pages 1068 - 1076
|
|
RIZKI ET AL., J. LIPID RES., vol. 47, 2006, pages 2280 - 2290
|
|
ROCHLANI ET AL., CARDIOVASCULAR DISEASE, 2017, pages 215 - 225
|
|
SCHAFER SVISWANATHAN SWIDJAJA AA ET AL.: "IL-11 is a crucial determinant of cardiovascular fibrosis", NATURE, vol. 552, 2017, pages 110 - 115
|
|
SCHERR, M.K. BATTMERA. GANSERM. EDER: "Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA", CELL CYCLE, vol. 2, 2003, pages 251 - 7
|
|
SCHERR, M.M.A. MORGANM. EDER.: "Gene silencing mediated by small interfering RNAs in mammalian cells", CURR MED CHEM., vol. 10, 2003, pages 245 - 56, XP009019025
|
|
SCHIER ET AL., GENE, vol. 169, 1995, pages 147 - 155
|
|
SCHNABL BPURBECK CACHOI YH ET AL.: "Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype", HEPATOLOGY, vol. 37, 2003, pages 653 - 664
|
|
SCHROEDERCAVACINI, J ALLERGY CLIN IMMUNOL., vol. 125, no. 202, 2010, pages S41 - S52
|
|
SEKI EDE MINICIS SOSTERREICHER CH ET AL.: "TLR4 enhances TGF-β signalling and hepatic fibrosis", NAT MED, vol. 13, 2007, pages 1324 - 1332
|
|
SHAH ET AL., J INFLAMM RES, vol. 11, 2018, pages 77 - 85
|
|
SHARP, P. A., RNA INTERFERENCE, 2001
|
|
SHEN ET AL., FEBS LETT, vol. 539, no. 1-3, 27 March 2003 (2003-03-27), pages 111 - 4
|
|
SHEN, C.A.K. BUCKX. LIUM. WINKLERS.N. RESKE: "Gene silencing by adenovirus-delivered siRNA", FEBS LETT., vol. 539, 2003, pages 111 - 4, XP004415445
|
|
SHENG JRUEDL CKARJALAINEN K: "Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells", IMMUNITY, vol. 43, 2015, pages 382 - 393
|
|
SHIN ET AL., RNA, vol. 15, no. 5, May 2009 (2009-05-01), pages 898 - 910
|
|
SHINAGAWA ET AL., GENES AND DEV., vol. 17, 2003, pages 1340 - 5
|
|
SHUEY, D.J.D.E. MCCALLUST. GIORDANO: "RNAi: gene-silencing in therapeutic intervention", DRUG DISCOV TODAY, vol. 7, 2002, pages 1040 - 6, XP002331644
|
|
SIMEONI, F.M.C. MORRISF. HEITZG. DIVITA: "Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells", NUCLEIC ACIDS RES., vol. 31, 2003, pages 2717 - 24, XP002984580
|
|
SIMON TGBAMIRA DGCHUNG RT ET AL.: "Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction", OBESITY, vol. 25, 2017, pages 1313 - 1316
|
|
SINHA, N. D.BIERNAT, J.MCMANUS, J.KOSTER, H., NUCLEIC ACIDS RES., vol. 12, 1984, pages 4539
|
|
SKIPWORTH ET AL., CLIN NUTR., vol. 26, 2007, pages 667 - 76
|
|
SODING, J., BIOINFORMATICS, vol. 21, 2005, pages 951 - 960
|
|
SONG, E.S.K. LEEJ. WANGN. INCEN. OUYANGJ. MINJ. CHENP. SHANKARJ. LIEBERMAN: "RNA interference targeting Fas protects mice from fulminant hepatitis", NAT MED., vol. 9, 2003, pages 347 - 51, XP002351920
|
|
SORENSEN, D.R.M. LEIRDALM. SIOUD: "Gene silencing by systemic delivery of synthetic siRNAs in adult mice", J MOL BIOL., vol. 327, 2003, pages 761 - 6, XP027101312
|
|
STEPHENSON KKENNEDY LHARGROVE L ET AL.: "Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights", GENE EXPR, vol. 18, 2018, pages 5 - 17
|
|
STRUYVENBERG ET AL., BMC MED, vol. 15, 2017, pages 29
|
|
SUBRAMANIAN ATAMAYO PMOOTHA VK ET AL.: "Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles", PROC NATL ACAD SCI U S A, vol. 102, 2005, pages 15545 - 15550, XP002464143
|
|
TAKI ET AL., CLIN EXP IMMUNOL, vol. 112, no. 1, April 1998 (1998-04-01), pages 133 - 138
|
|
TISDALE, NATURE REVIEWS CANCER, vol. 2, 2002, pages 862 - 871
|
|
TSUCHIDA TFRIEDMAN SL: "Mechanisms of hepatic stellate cell activation", NAT REV GASTROENTEROL HEPATOL, vol. 14, 2017, pages 397 - 411
|
|
TUERKGOLD, SCIENCE, vol. 249, no. 4968, 1990, pages 505 - 10
|
|
TUSCHL, T., CHEM. BIOCHEM., vol. 2, 2001, pages 239 - 245
|
|
UNDERHILL-DAY ET AL., ENDOCRINOLOGY, vol. 144, no. 8, August 2003 (2003-08-01), pages 3406 - 14
|
|
VAUGHAN ET AL., J CACHEXIA SARCOPENIA MUSCLE, vol. 4, 2013, pages 173 - 109
|
|
WANG ET AL., AAPS J., vol. 12, no. 4, December 2010 (2010-12-01), pages 492 - 503
|
|
WEWER ALBRECHTSEN ET AL., BIOMARK MED., vol. 11, 2016, pages 1141 - 1151
|
|
WORTHAM MHE LGYAMFI M ET AL.: "The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet", DIG DIS SCI, vol. 53, 2008, pages 2761 - 2774, XP019602662
|
|
WOZNIAK-KNOPP G ET AL., PROTEIN ENG DES, vol. 23, no. 4, 2010, pages 289 - 297
|
|
WRIGHT ET AL., MOL. CELL. BIOL., vol. 30, no. 6, March 2010 (2010-03-01), pages 1411 - 1420
|
|
YANG CZEISBERG MMOSTERMAN B ET AL.: "Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors", GASTROENTEROLOGY, vol. 124, 2003, pages 147 - 159
|
|
YASUI KSUMIDA YMORI Y ET AL.: "Nonalcoholic steatohepatitis and increased risk of chronic kidney disease", METABOLISM, vol. 60, 2011, pages 735 - 739
|
|
YATA Y: "DNase I-hypersensitive sites enhance a1 (I) collagen gene expression in hepatic stellate cells", HEPATOLOGY, vol. 37, 2003, pages 267 - 276
|
|
YEREVANIAN ET AL., CURR OBES REP, 2019
|
|
YU JFENG ZTAN L ET AL.: "Interleukin-11 protects mouse liver from warm ischemia/reperfusion (WI/Rp) injury", CLIN RES HEPATOL GASTROENTEROL, vol. 40, 2016, pages 562 - 570
|
|
ZAMORE, P. D. ET AL., CELL, vol. 101, 2000, pages 25 - 33
|
|
ZHU MLU BCAO Q ET AL.: "IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signalling Pathway in Mice", PLOS ONE, vol. 10, 2015, pages e0126296
|